Published in J Bacteriol on October 01, 1964
IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1965) 4.16
Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis. J Bacteriol (1966) 3.07
Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate. J Bacteriol (1966) 2.89
Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium. J Bacteriol (1969) 2.72
Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations. J Bacteriol (1969) 2.35
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun (1975) 1.74
Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium. Infect Immun (1976) 1.63
Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium. Infect Immun (1978) 1.56
Specificity of the anamnestic response produced by Listeria monocytogenes or Mycobacterium tuberculosis to challenge with Listeria monocytogenes. J Bacteriol (1969) 1.55
Nonspecific factors in resistance of mice to experimental tuberculosis. J Bacteriol (1965) 1.53
Specificity of Acquired Resistance Produced by Immunization with Listeria monocytogenes and Listeria Fractions. J Bacteriol (1969) 1.34
Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun (1981) 1.33
Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium. Infect Immun (1976) 1.32
Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions. J Bacteriol (1969) 1.28
Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans. Infect Immun (1978) 0.97
Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun (1979) 0.93
Resolution and identification of ribosomes from mycobacteria. J Bacteriol (1968) 0.88
Immunogenic capacity of ribosomes of Salmonella typhi interfered with a flagellin-like material contaminant. Infect Immun (1978) 0.81
Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid. Infect Immun (1981) 0.79
A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens. J Immunol Methods (2011) 0.78
Liver microsomes; an integrated morphological and biochemical study. J Biophys Biochem Cytol (1956) 19.70
The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis. J Immunol (1957) 3.60
The effect of tonicity of the medium on the respiratory and phosphorylative activity of heart-muscle sarcosomes. Biochem J (1953) 2.59
Reversal of various types of mitochondrial swelling by adenosine triphosphate. J Biol Chem (1959) 2.24
The immunizing activity against tuberculous infection in mice of enzymatically active particles isolated from extracts of Mycobacterium tuberculosis. J Bacteriol (1955) 2.13
Immunogenicity of intracellular particles and cell walls from Mycobacterium tuberculosis. J Bacteriol (1960) 1.78
FURTHER STUDIES ON A LABILE IMMUNOGENIC PARTICULATE SUBSTANCE ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.72
Bacterial particles in oxidative phosphorylation. Science (1957) 1.58
EFFECT OF MITOCHONDRIAL STABILIZERS ON THE IMMUNOGENICITY OF THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.46
Studies on mitochondria. VI. The relationship between the structure, osmotic reactivity and ATPase activity of mitochondria from pigeon skeletal muscle. Exp Cell Res (1955) 1.37
Enzyme localization in bacteria. Annu Rev Microbiol (1960) 1.34
Immunogenicity of particles isolated from Mycobacterium tuberculosis. Proc Soc Exp Biol Med (1957) 1.25
The mitochondrion and biochemical machines. Science (1961) 1.10
IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1965) 4.16
The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis. J Immunol (1957) 3.60
Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice. Am Rev Tuberc (1957) 3.01
AN ACUTE PULMONARY GRANULOMATOUS RESPONSE IN MICE PRODUCED BY MYCOBACTERIAL CELLS AND ITS RELATION TO INCREASED RESISTANCE AND INCREASED SUSCEPTIBILITY TO EXPERIMENTAL TUBERCULOUS INFECTION. J Infect Dis (1964) 2.29
The immunizing activity against tuberculous infection in mice of enzymatically active particles isolated from extracts of Mycobacterium tuberculosis. J Bacteriol (1955) 2.13
The relation between the size of the infecting dose of tubercle bacilli and the survival time of mice. Am Rev Tuberc (1951) 2.03
The characterization of the terminal respiratory enzymes of the H37Ra strain of mycobacterium tuberculosis var. hominis. J Bacteriol (1955) 1.99
Studies in tuberculosis chemotherapy; a simple primary aromatic amines, in vitro and in vivo. Am Rev Tuberc (1950) 1.80
Immunogenicity of intracellular particles and cell walls from Mycobacterium tuberculosis. J Bacteriol (1960) 1.78
An evaluation of the specificty and sensitivity of a gel double-diffusion test for tuberculosis. Am Rev Respir Dis (1959) 1.76
FURTHER STUDIES ON A LABILE IMMUNOGENIC PARTICULATE SUBSTANCE ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.72
The growth of recently isolated strains of Mycobacterium tuberculosis var. hominis in liquid media. J Bacteriol (1950) 1.67
The inability of p-aminosalicylic acid to delay the emergence of streptomycin resistant tubercle bacilli in mice. Am Rev Tuberc (1950) 1.63
The enumeration of nonpathogenic viable tubercle bacilli from the organs of mice. Am Rev Tuberc (1957) 1.56
Allergenicity of intracellular particles, cell walls, and cytoplasmic fluid from Mycobacterium tuberculosis. J Bacteriol (1960) 1.55
The difference in response of four strains of mice to immunization against tuberculous infection. Am Rev Respir Dis (1959) 1.53
Studies on the metabolism of mycobacterim tuberculosis. VII. Terminal respiratory activity of an avirulent strain of Mycobacterium tuberculosis. J Bacteriol (1954) 1.47
EFFECT OF MITOCHONDRIAL STABILIZERS ON THE IMMUNOGENICITY OF THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.46
Studies on the metabolism of Mycobacterium tuberculosis. I. The effect of carbohydrates and alcohols on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol (1953) 1.43
Studies on the metabolism of Mycobacterium tuberculosis. VI. The effect of Krebs' tricarboxylic acid cycle intermediates and precursors on the growth and respiration of Mycobacterium tuberculosis. J Bacteriol (1954) 1.42
The oxidation of compounds related to the tricarboxylic acid cycle by whole cells and enzyme preparations of Mycobacterium tuberculosis var. hominis. J Bacteriol (1956) 1.27
Immunogenicity of particles isolated from Mycobacterium tuberculosis. Proc Soc Exp Biol Med (1957) 1.25
THE PATHOGENIC "ATYPICAL" MYCOBACTERIA. Annu Rev Microbiol (1963) 1.20
Studies on the metabolism of Mycobacterium tuberculosis. II. The effect of compounds related to the Kreb's tricarboxylic acid cycle on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol (1953) 1.20
Effect of homogenates of organs from immunized guinea pigs on the respiration of Mycobacterium tuberculosis. J Bacteriol (1960) 1.13
The effect of bovine plasma fractions on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol (1950) 1.11
The detection of antibodies in the serum of tuberculous patients by an agar double-diffusion precipitation technique. Am Rev Tuberc (1958) 1.11
The assessment of antituberculous chemotherapeutic activity in mice, using virulent human-type tubercle bacilli. Am Rev Tuberc (1951) 1.09
The effect of macrocyclon on the multiplication of tubercle bacilli in the lungs and spleen of mice. Br J Exp Pathol (1960) 1.08
The effect of thiocarbanidin and related compounds on Mycobacterium tuberculosis var. hominis in vitro and in vivo. Am Rev Tuberc (1958) 1.03
Studies on the metabolism of Mycobacterium tuberculosis. IV. The effect of fatty acids on the growth of M. tuberculosis var. hominis. J Bacteriol (1954) 1.03
Effect of mycosuppressin on the respiration and growth of Mycobacterium tuberculosis. J Bacteriol (1962) 1.01
The significance of the response of mice to immunization with viable unclassified mycobacteria. Am Rev Respir Dis (1961) 1.00
Acquired immunity in tuberculosis. J Chronic Dis (1957) 0.99
Studies on the metabolism of Mycobacterium tuberculosis. III. The growth of Mycobacterium tuberculosis var. hominis in the presence of various intermediates of the dissimilation of glucose to pyruvic acid. J Bacteriol (1953) 0.99
Effect of mycosuppressin on the course of experimental tuberculosis in mice. J Bacteriol (1962) 0.98
Antigenic relationships between mycobacteria as determined by agar diffusion precipitin techniques. Am Rev Tuberc (1956) 0.96
Test tube evaluation of tuberculostatic agents. Am Rev Tuberc (1947) 0.96
Studies on the metabolism of Mycobacterium tuberculosis. V. The effect of amino acids on the growth of M. tuberculosis var. hominis. J Bacteriol (1954) 0.95
The relation of oxygen tension to virulence of tubercle bacilli and to acquired resistance in tuberculosis. J Infect Dis (1958) 0.95
The relationship of sex to the susceptibility of normal and immunized mice to tuberculosis. Am Rev Respir Dis (1959) 0.91
The inactivation of isoniazid by filtrates and extracts of mycobacteria. Am Rev Tuberc (1955) 0.90
Studies on the metabolism of virulent and avirulent mycobacteria. Am Rev Tuberc (1952) 0.90
Lysozyme treatment of tuberculous mice. J Infect Dis (1958) 0.90
Duration of the infection in scarlet fever. Ann Intern Med (1950) 0.87
Antigenic relationships between ninety-eight strains of mycobacteria using gel-diffusion precipitation techniques. Am Rev Tuberc (1958) 0.86
The effect of hormonal preparations on the survival of mice injected intravenously with virulent, attenuated, and avirulent Mycobacteria. Am Rev Tuberc (1954) 0.83
Streptomycin sensitivity of tubercle bacilli; studies on recently isolated tubercle bacilli and the development of resistance to streptomycin in vivo. Am Rev Tuberc (1947) 0.83
Response of mice to standard infecting doses of Mycobacterium tuberculosis var. hominis. Proc Soc Exp Biol Med (1955) 0.79
Increase in resistance of tubercle bacilli to streptomycin; a preliminary report. Proc Staff Meet Mayo Clin (1946) 0.77
Streptomycin in experimental tuberculosis; its effect on tuberculous infections in mice produced by M. tuberculosis var. hominis. Am Rev Tuberc (1945) 0.77
Streptomycin resistant variants obtained from recently isolated cultures of tubercle bacilli. Proc Soc Exp Biol Med (1948) 0.76
Elaiomycin, a new tuberculostatic antibiotic; biologic studies. Antibiot Chemother (Northfield) (1954) 0.76
The effect of tween 80 in vitro on the bacteriostatic activity of 20 compounds for Mycobacterium tuberculosis. J Bacteriol (1948) 0.75
Studies on the delay in the bacteriostatic action of sulfanilamide on Escherichia coli. J Bacteriol (1947) 0.75
Factors affecting the sensitivity in vitro of tubercle bacilli to streptomycin. Am Rev Tuberc (1949) 0.75
The use of mice in experimental chemotherapy of tuberculosis; pathology and pathogenesis. J Infect Dis (1948) 0.75
Occurrence of streptomycin resistant tubercle bacilli in mice treated with streptomycin. Proc Soc Exp Biol Med (1949) 0.75
Isolation of tubercle bacilli from feces and gastric contents of intravenously infected mice. Am Rev Tuberc (1950) 0.75
The use of mice in experimental chemotherapy of tuberculosis; rationale and review of the literature. J Infect Dis (1948) 0.75
The development in vitro of an avirulent, immunogenic variant of Mycobacterium tuberculosis var. hominis. Proc Soc Exp Biol Med (1956) 0.75
The effect of viomycin in vitro and in vivo on Mycobacterium tuberculosis. Am Rev Tuberc (1951) 0.75
The effect of bovine plasma on the tuberculostatic activity of gamma-pheroxypropylamine. Antibiot Chemother (Northfield) (1954) 0.75
The combined effect of streptomycin and para-aminosalicylic acid on experimental tuberculosis in mice. J Lancet (1947) 0.75
The use of the mouse for the testing of chemotherapeutic agents against Mycobacterium tuberculosis. Ann N Y Acad Sci (1949) 0.75
Tuberculostatic action of chloromycetin in vitro and in vivo. Proc Soc Exp Biol Med (1948) 0.75
The use of mice in experimental chemotherapy of tuberculosis; the histopathologic assay of chemotherapeutic action. J Infect Dis (1948) 0.75